C

Cantargia AB

35 employees

Cantargia develops a therapy for the treatment of cancer by targeting a unique cell-surface receptor on malignant stem cells.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical Device
Therapeutics

Date founded

2010

Funding rounds raised

Total raised

$1M

from 1 investors over 1 rounds

C

Cantargia AB raised $1M on July 5, 2013

Investors: Sunstone Life Science Ventures

FAQ